תבנית:תרופה/סימביקורט טורבוהלר 160/4.5 מק"ג/מנה - Symbicort turbuhaler 160/4.5 mcg/dose: הבדלים בין גרסאות

Asthma Symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - Patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. COPD Symptomatic treatment of patients with severe COPD (FEV1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.